Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IPIX is dead. $400 volume and according to the filings the CEO plans to funnel remaining capital into “other” investments.
The CEO mentioned Regeneron the day IPIX died. 120,000,000 shares dumped by longs who simply had enough of this regurgitated bullshit.
The price has dropped another 80-90% since that day.
http://www.ipharminc.com/press-release/2021/11/11/innovation-pharmaceuticals-announces-topline-results-from-phase-2-clinical-trial-of-brilacidin-for-covid-19
Here’s another example - Today I sent an email with links to recent publications on the Ipix B product to my Licensing and Business Development responsible contact at the EU company. They sent reply with confirmation they will "discuss the project" in the next internal licensing meeting now in about 2 weeks.
Snake oil.
Here’s another example - Investor Relations spoke to Licensing and confirmed plans to discuss Ipix B product in an April meeting.
Here is an example - Director Investor Relations in the EU company confirms contact with the Licensing responsible and the plan to discuss Ipix
What a joke.
“Screws” should be inserted between picks and steals!
Dog, wife, whatever….
COVID - a contributor to IPIX’s death.
As I’ve said over and over and over and over and over and over and over….
Shit’s dead and headed to ZERO.
What a shitshow. Bagholders are screwed.
IPIX is dead.
Within one thousandth not close enough?
Smoke and mirrors.
Smoke and mirrors. IPIX is dead.
He has nothing else to offer because he has no cash and no one with cash that trusts him or the petri dish science led by his “advisors”.
In all fairness, the CEO did mention he’s looking for “other” investment opportunities. LOL.
And don’t forget ur scuba gear!
To your point…. DeGrado’s most recent blunder. The publication that broke the bank.
https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.27616
CONFLICT OF INTERESTS:
William F. DeGrado is a member of the scientific advisory board of Innovation Pharmaceuticals, a company that is conducting clinical trials on brilacidin.
New investors, please join us in our misery and become fellow bagholders!
Lower lows ahead. Much lower.
No one is buying it. Dead.
That ship sailed long ago and sank.
Clearly no one’s buying the made up IPIX stories, brilacidin or IPIX for that matter. The market has spoken. Zero trust in management. There’s no disputing these facts. Everyone here has witnessed the demise of this company. Smoke and mirrors and illusions of truth are all that exists by those left holding the bag.
This turds toast. Well on its way to zero. Lower lows just ahead.
Illusion of truth - “A European pharmaceutical company will discuss Brilacidin in their internal licensing meeting in 3 weeks. I know this direct from the company and not from Ipix. We will see how the Ipix stories change into the future.”
Illusion of truth
-Investor Relations spoke to Licensing and confirmed plans to discuss Ipix B product in an April meeting. I have some contact with both responsible Directors in the EU company.
-Excellent potential and value in Brilacidin.
-Tested in laboratories and hospitals and humans all around the big world. Anti-bacterial and anti-viral and anti-fungal and anti-inflammatory.
-I am happy I bought an other big bag full of Ipix action below USD$.015.
-I am buying it
-development deal with a good EU partner
-1/3 owner share of a new laser surgery treatment
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171556989
illusion of truth
No one is buying it.
IPIX
Innovation Pharmaceuticals Inc (QB)
0.0175 -0.001 (-5.41%)
Bid: 0.015
Ask: 0.079
Last Trade Time: 3:48:15 PM EDT
Total Trades: 22
Bagholders are screwed.
Dead.
Innovation Pharmaceuticals (QB)
Quote Info
Support 1 0.016367
Support 2 0.015233
Pivot Price 0.018133
Resistance 1 0.019267
Resistance 2 0.021033
Trades 22
52 Week Range 0.0111 - 0.0649
VWAP $ 0.01744
Dollar Volume $ 7,839
Volume 449,471
Currency USD
Market OTCMarkets
Type Common Stock
Dead, buried, never to be resurrected.
We’ve been around long enough to know better.
New investors please join us in our misery and become fellow bagholders.
Pathetic.